Skip to main content
Premium Trial:

Request an Annual Quote

Larry Pease, Dale Wahlstrom, Charles Muscoplat, Leonard Ruiz, Dave Melin, Ian Troup, Lynn Schoessler, Maz Khan, Joy Gustat

Six Named to Advisory Board of Minnesota’s Biotechnology Center at Elk Run
Tower Investments, the developer of the proposed 2,325-acre Biotechnology Center at Elk Run — a bioscience and residential campus planned along US 52 near Pine Island, Minn. — has named six members to an advisory board, according to the Post-Bulletin of Rochester Minn.
The group will help choose early-stage companies for the nonprofit center, which is planned to be the first structure built later this year on the campus, located about 18 miles north of Rochester.
The six advisory board members are:
  • Larry Pease, a researcher at Mayo Clinic’s Cancer Immunology and Immunotherapy Program. Pease has developed a human antibody from stored blood serum capable of fighting malignant melanoma and blocking an inflammatory lung disease that resembles asthma in experimental animal models.
  • Dale Wahlstrom, CEO of the BioBusiness Alliance of Minnesota, the state’s life sciences industry group. He previously spent 24 years at Medtronic, retiring as vice president of cardiac rhythm disease management venture programs.
  • Charles Muscoplat, vice president for statewide strategic resource development at the University of Minnesota.
  • Leonard Ruiz, CEO of BIOVIRx, a nonprofit immunization organization with offices in the Premier Bank building near Rochester's downtown.
  • Dave Melin, vice president of corporate and government affairs for MGI Pharma in Bloomington, Minn.
  • Ian Troup, a director and former board chairman for Medisyn Technologies, a Minnetonka, Minn., developer of pre-qualified proprietary drug compounds, and a former COO of Upsher-Smith Laboratories.
Marks told the newspaper the nonprofit center would fill a gap in Minnesota's biotechnology industry between conventional incubators and Rochester's Biobusiness Center, which assists established businesses.
"Our goal is keeping jobs in Minnesota by having these companies in the early development stages work here instead of moving to California or Florida or Massachusetts," Alex Marks, senior vice president of Tower, told the Post-Bulletin. "We thought this would be the best way of sticking a stake in the ground and building off a group of companies which will expand someday.”

Housing Manager Named Deputy Director for Oregon Economic Development Agency
Lynn Schoessler, the housing finance section manager with Oregon's Housing and Community Services department, has been named deputy director of the state’s Economic and Community Development Department.  He started June 4 in his new position as the department’s second-highest ranking official behind acting director Tim McCabe.
The move is part of a restructuring of the economic development department intended to spark more business development activity. Unlike other states, Oregon’s economic development office had doubled as a provider of public works services – a dual purpose that officials now believe detracted from the department’s job attraction and retention efforts.
Schoessler served as housing programs director for a regional Community Action Agency in La Grande, and later was executive director of the regional housing authority in La Grande that served Baker, Union, Wallowa, and Grant Counties.

Schoessler joined the staff of the Oregon Housing Agency, the predecessor agency of the Oregon Housing and Community Services Department, in 1988. Two years later, Schoessler became the deputy director of Oregon Housing and Community Services Department and served three consecutive directors in that position.

In 1999, President Bill Clinton named Schoessler Oregon’s director of Rural Development, an agency within the US Department of Agriculture. Schoessler transitioned to the Bush administration and continued as state director until April 2005, when he rejoined Housing and Community Services.


Frost & Sullivan Appoints Maz Khan to Lead Its Pharmaceutical Team in Australia
Maz Khan has been appointed by the global market research firm Frost and Sullivan as director for the pharmaceutical team in Australia.
Khan will oversee a planned expansion of the team, and work to increase its visibility as well as work with clients to generate and evaluate market data, then implement their strategic plans. Khan previously led market research and business intelligence functions at Eli Lilly, Aventis, and Wyeth.
Frost and Sullivan’s healthcare practice has more than 90 analysts in the Asia/Pacific region dedicated to research in the pharmaceuticals, medical devices, biotechnology, and healthcare IT markets, as well as emerging technology trends in the region. The firm said it foresees more interest in its cost-benefit studies of new diagnostics.

IFMA’s Boston Chapter Honors Business Development-Marketing Manager
Joy Gustat, business development-marketing manager for Diversified Project Management, a provider of services for building owners, has won the Distinguished Associate Member Award from the International Facility Management Association.
The award is given to an associate member who has contributed what IFMA deems significant time and effort in support of one of its chapters, and the facility management profession.
Since 2005, Joy has co-chaired the IFMA Boston Membership Committee, helping it reach its current record-high membership of 804, making it the second largest chapter in the world. She has also served on the IFMA Golf Committee since 2004 and volunteered at the annual tournament for the past six years. Joy has also coordinated many IFMA events, including bi-annual new membership breakfasts, this past year's Chapter of the Year party, and all Boston chapter events at the IFMA World Workplace Conference & Expo in San Diego and New Orleans.
Gustat received her award at IFMA’s 5th Annual Awards Dinner.
Diversified Project Management has offices in Newton, Mass., as well as Hartford, Conn., and Stamford, Conn.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.